New drug BAT8010 tested in 23 patients with advanced cancer
Disease control
Completed
This early-phase study tested a new drug called BAT8010 in 23 people with advanced or spreading solid tumors who had no other standard treatment options. The main goals were to check the drug's safety, find the highest safe dose, and see if it could shrink tumors. Participants re…
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC